RESMED INC — Director's Dealing 2019

Nov 19, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2019-11-15

Reporting Person: Hollingshead James (President, Sleep Business)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-15	ResMed Common Stock	M	1717	$58.24	Acquired	82349	Direct
2019-11-15	ResMed Common Stock	M	20038	$58.24	Acquired	102387	Direct
2019-11-15	ResMed Common Stock	S	20038	$146.35	Disposed	82349	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-11-15	ResMed Common Stock Options	$58.24	M	1717	Disposed	2022-11-19	ResMed Commmon Stock (1717)	Direct
2019-11-15	ResMed Common Stock Options	$58.24	M	20038	Disposed	2022-11-19	ResMed Commmon Stock (20038)	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $146.07 to 146.80. The price reported above reflects the weighted average sale price.

F2: Represents date options first became exercisable. Options vest 1/3 per year.